Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Postoperative Wound Healing
NCT06400082Active, not recruiting
- Sponsor
- Cairo University
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Generex Oral-lyn in surgical wound (2 arms), sponsored by Cairo University. Primary endpoint: Unit Healing Time index at 7 days. Started Apr 2023; status: active, not recruiting.
02
Drugs
Generex Oral-lyn
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT06400082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400082.